CVS Health shows strong growth with strategic shifts, improved Medicare ratings, and promising earnings. Read why I see CVS ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

CVS Health ( NYSE: CVS) on Thursday announced plans to discontinue operations in the individual health insurance business, ...

CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare benefits contributed to a better ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

CVS Health topped Q1 estimates with $94.59 billion in revenue and raised 2025 EPS outlook to $6.00–$6.20 amid strong Medicare ...

CVS Health (CVS) is one of the stocks most watched ... Over the past month, shares of this drugstore chain and pharmacy benefits manager have returned +5.1%, compared to the Zacks S&P 500 ...

For the first time, pharmacy benefit manager parent companies including CVS Health, Cigna and UnitedHealth Group must decide between running moneymaking PBMs or patient-facing pharmacies in a state.

Erik McGregor / LightRocket via Getty Images Shares of CVS Health surged as the company's first-quarter results easily topped estimates. The pharmacy and health insurance firm lifted its full-year ...